Cell Medica Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Cell Medica Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C0480
◆発行会社(調査会社):GlobalData
◆発行日:2018年7月
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Cell Medica Ltd (Cell Medica), formerly Immunocode Ltd manufactures and commercializes cellular products. The company uses various technology platforms such as chimeric antigen receptor (CAR), Dominant T cell receptor (TCR), PENTRA Antibody technology and NKT cell platform for manufacturing gene-modified immune cell products. Its pipeline products include CAR-NKT Cells, Dominant TCR and EBV- Targeted T Cells. Cell Medica collaborates with academic institutions to harness human immune system for the treatment of cancer. The company operates in Switzerland, the UK and the US. Cell Medica is headquartered in London, the UK.

Cell Medica Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Cell Medica Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Cell Medica Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Cell Medica Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Cell Medica Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Cell Medica Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Cell Medica Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Cell Medica Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Cell Medica Raises USD73.2 Million in Series C Financing 11
Cell Medica Raises USD78.3 Million in Series B Venture Financing 12
Delenex Therapeutics Raises US$8 Million In Series A3 Financing 13
Cell Medica Raises US$11 Million In Venture Financing 14
Partnerships 15
Cell Medica Enters into Partnership with University College London 15
Licensing Agreements 16
Cell Medica Extends Licensing Agreement with Baylor College of Medicine 16
Acquisition 18
Cell Medica Acquires Catapult Therapy TCR from Cell Therapy Catapult 18
Cell Medica Acquires Remaining 73% Stake in Delenex Therapeutics 19
Cell Medica Ltd – Key Competitors 20
Cell Medica Ltd – Key Employees 21
Cell Medica Ltd – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Corporate Communications 23
Jun 13, 2018: Cell Medica Names Julia P. Gregory As Non-Executive Director And Audit Chair 23
Feb 16, 2018: Cell Medica Appoints Kevin S. Boyle As CFO 24
Dec 07, 2017: Cell Medica Announces Appointment of Industry Leader Dr Annalisa Jenkins as Chair 25
Sep 18, 2017: Cell Medica Appoints CSO to Accelerate R&D for CAR and TCR Programmes 26
Product Approvals 27
Feb 21, 2017: Lead cancer immunotherapy candidate receives FDA fast track designation 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Cell Medica Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Cell Medica Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Cell Medica Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Cell Medica Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Cell Medica Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Cell Medica Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Cell Medica Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Cell Medica Raises USD73.2 Million in Series C Financing 11
Cell Medica Raises USD78.3 Million in Series B Venture Financing 12
Delenex Therapeutics Raises US$8 Million In Series A3 Financing 13
Cell Medica Raises US$11 Million In Venture Financing 14
Cell Medica Enters into Partnership with University College London 15
Cell Medica Extends Licensing Agreement with Baylor College of Medicine 16
Cell Medica Acquires Catapult Therapy TCR from Cell Therapy Catapult 18
Cell Medica Acquires Remaining 73% Stake in Delenex Therapeutics 19
Cell Medica Ltd, Key Competitors 20
Cell Medica Ltd, Key Employees 21
Cell Medica Ltd, Other Locations 22
Cell Medica Ltd, Subsidiaries 22

List of Figures
Cell Medica Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Cell Medica Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Cell Medica Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Cell Medica Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Cell Medica Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Cell Medica Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Cell Medica Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Cell Medica Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Cell Medica Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Cell Medica Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • InterHealth Nutraceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary InterHealth Nutraceuticals Inc (InterHealth), a subsidiary of Lonza Group Ltd, is a developer, manufacturer and distributor of nutraceutical ingredients. The company offers nutritional ingredients such as Zychrome, Meratrim, LOWAT, Super CitriMax, ChromeMate, L-OptiZinc, Protykin, ZMA, UC-II …
  • Dino Polska S.A (DNP):企業の財務・戦略的SWOT分析
    Dino Polska S.A (DNP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • PT Cikarang Listrindo (POWR):電力:M&Aディール及び事業提携情報
    Summary PT Cikarang Listrindo (Cikarang Listrindo) is a power company that generates and distributes electricity. The company offers services such as 24hours customer hotline, well trained security team, substation maintenance and calibration of kilo watt hour meters. It caters to automobile, electr …
  • East Energy Resources Limited:企業の戦略・SWOT・財務情報
    East Energy Resources Limited - Strategy, SWOT and Corporate Finance Report Summary East Energy Resources Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • VivaCell Biotechnology Espana SL:製薬・医療:M&Aディール及び事業提携情報
    Summary VivaCell Biotechnology Espana SL (VivaCell Biotechnology), a subsidiary of VivaCell Biotechnology GmbH, is a preclinical-stage pharmaceutical company that develops medicinal derivatives. The company's products comprise CDE-001, VCE-003.2 and VCE-004.8. It provides research and development, c …
  • Mitsui & Co., Ltd.:企業の戦略・SWOT・財務分析
    Mitsui & Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Mitsui & Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Whatabrands LLC:企業の戦略・SWOT・財務情報
    Whatabrands LLC - Strategy, SWOT and Corporate Finance Report Summary Whatabrands LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Sunningdale Tech Ltd (BHQ):企業の財務・戦略的SWOT分析
    Summary Sunningdale Tech Ltd (Sunningdale) is a chemical company that manufactures and markets tooling and plastic injection moulding components. The company's plastic solutions include product and mould designs, injection moulding, mould fabrication, complementary finishings, and precision assembly …
  • Mediware Information Systems Inc-医療機器分野:企業M&A・提携分析
    Summary Mediware Information Systems Inc (Mediware) is a healthcare solutions company that designs, develops and commercializes specialized healthcare software. It provides software to healthcare and human service providers and payers. The company’s portfolio of solutions are equipped in blood banks …
  • E.ON SE (EOAN):石油・ガス:M&Aディール及び事業提携情報
    Summary E.ON SE(E.ON), formerly E.ON AG, is an energy company that generates electricity, produces, stores, transports and supplies gas, and conducts trading, carbon sourcing, and electricity and gas distribution. It generates power from diverse fuel sources including wind, hydro, nuclear, coal, nat …
  • Immunodiagnostic Systems Holdings plc (IDH):企業の財務・戦略的SWOT分析
    Summary Immunodiagnostic Systems Holdings plc (IDS) is an in-vitro diagnostic solution provider that develops, manufactures and markets immunoassays and automated immunoanalyser technologies. The company conducts research in the areas of bone turnover market, animal research, and other research area …
  • Terna Energy SA (TENERGY):企業の財務・戦略的SWOT分析
    Terna Energy SA (TENERGY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Saturn NPO:企業の戦略・SWOT・財務情報
    Saturn NPO - Strategy, SWOT and Corporate Finance Report Summary Saturn NPO - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Kamada Ltd (KMDA):製薬・医療:M&Aディール及び事業提携情報
    Summary Kamada Ltd (Kamada) is a biopharmaceutical company that develops, manufactures and markets specialty proteins, specific immunoglobulins and other prescription medicines. Its major products include pulmonary related medicines, immunoglobins, vaccines and critical care medicines. It also offer …
  • U.S. Bancorp:戦略・SWOT・企業財務分析
    U.S. Bancorp - Strategy, SWOT and Corporate Finance Report Summary U.S. Bancorp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • E-L Financial Corporation Limited:企業の戦略・SWOT・財務情報
    E-L Financial Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary E-L Financial Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • WPX Energy Inc (WPX):石油・ガス:M&Aディール及び事業提携情報
    Summary WPX Energy Inc (WPX Energy) is an oil and gas company that carries out drilling and exploration activities. The company exploits and develops unconventional properties. It produces natural gas, natural gas liquids and crude oil from non-conventional resources including tight-sands, shale for …
  • CONSOL Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    CONSOL Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary CONSOL Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on …
  • 3-D Matrix Inc:企業の戦略的SWOT分析
    3-D Matrix Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Tata Communications Ltd (TATACOMM):企業の財務・戦略的SWOT分析
    Tata Communications Ltd (TATACOMM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆